胆固醇吸收合成标志物研究进展

被引：5

作者：

白娜

任洁

机构：

[1] 山西医科大学附属山西大医院心内科

来源：

心血管病学进展 | 2015年 / 36卷 / 03期

关键词：

胆固醇吸收; 胆固醇合成; 标志物;

D O I：

暂无

中图分类号：

R96 [药理学];

学科分类号：

100602 ; 100706 ;

摘要：

国外大量研究已证明胆固醇吸收标志物(菜油甾醇、谷固醇、胆甾烷醇等)代表胆固醇吸收,胆固醇合成标志物(7-烯胆烷醇、角鲨烯、琏甾醇等)代表胆固醇合成,并将这些标志物用于血脂代谢异常的流行病学研究、临床降脂药物疗效评价及胆固醇代谢的实验研究,取得良好效果。现将胆固醇吸收合成标志物的研究进展做一综述。

引用

页码：315 / 319

页数：5

共 15 条

[1]

Reply to Letter to the Editor: “High Intestinal Cholesterol Absorption Is Associated With Cardiovascular Disease and Risk Alleles in ABCG8 and ABO : Evidence From the LURIC and YFS Cohorts and From a Meta-Analysis”[J] . Günther Silbernagel,M. John Chapman,Bernd Genser,Marcus E. Kleber,Günter Fauler,Hubert Scharnagl,Tanja B. Grammer,Kari-Matti M?kel?,Mika K?h?nen,Rafael Carmena,Ernst R. Rietzschel,Eric Bruckert,John E. Deanfield,Olli T. Raitakari,Terho Lehtim?ki,Winfried M?rz.Journal of the Ameri

[2] Gas chromatography analysis of serum cholesterol synthesis and absorption markers used to predict the efficacy of simvastatin in patients with coronary heart disease [J].

Wu, Wen-Feng ;

Wang, Qi-Hui ;

Zhang, Tao ;

Mi, Shu-Hua ;

Liu, Yang ;

Wang, Lv-Ya .

CLINICAL BIOCHEMISTRY, 2013, 46 (12) :993-998

[3] Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction [J].

Toth, Peter P. ;

Ballantyne, Christie M. ;

Davidson, Michael H. ;

Tomassini, Joanne E. ;

Ramey, Dena Rosen ;

Neff, David ;

Tershakovec, Andrew M. ;

Hu, X. Henry ;

Tunceli, Kaan .

JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (02) :180-191

[4]

Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men[J] . M.J. Nissinen,T.E. Miettinen,H. Gylling,T.A. Miettinen.Nutrition, Metabolism and Cardiovascular Diseases . 2009 (5)

[5]

Adolescent cholesterol metabolism predicts coronary risk factors at middle age: the Cardiovascular Risk in Young Finns Study[J] . Tatu A. Miettinen,Helena Gylling,Olli T. Raitakari,Maarit Hallikainen,Jorma Viikari.Translational Research . 2008 (5)

[6] SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment [J].

Berthold, H. K. ;

Laaksonen, R. ;

Lehtimaeki, T. ;

Gylling, H. ;

Krone, W. ;

Gouni-Berthold, I. .

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (05) :262-267

[7] Cholesterol synthesis prevails over absorption in metabolic syndrome [J].

Gylling, Helena ;

Hallikainen, Maarit ;

Kolehmainen, Marjukka ;

Toppinen, Leena ;

Pihlajamaki, Jussi ;

Mykkanen, Hannu ;

Agren, Jyri J. ;

Rauramaa, Rainer ;

Laakso, Markku ;

Miettinen, Tatu A. .

TRANSLATIONAL RESEARCH, 2007, 149 (06) :310-316

[8] Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM study [J].

Assmann, Gerd ;

Cullen, Paul ;

Kannenberg, Frank ;

Schulte, Helmut .

EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14 (02) :208-214

[9]

The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes[J] . Piia Simonen,Helena Gylling,Tatu A. Miettinen.Atherosclerosis . 2007 (2)

[10]

Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment[J] . Tatu A. Miettinen,Helena Gylling.Clinica Chimica Acta . 2006 (1)

← 1 2 →